1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CONCORD DRUGS LTD.
Concord Drugs Ltd. BSE: 538965

Concord Drugs Ltd. Live Share Price Today, Share Analysis and Chart

Turnaround Potential
about

Concord Drugs principal activity is to manufacture licensed drugs based on the formulations approved.

Read More
57.12 1.12 (2.00%)
118.85% Gain from 52W Low
7,426
BSE Volume

BSE 31 Jul, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
46.2 / 100
Momentum Score
Technically Moderately Bullish
66.1 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
No estimates available

13

S

9

W

0

O

0

T

SWOT Analysis

Concord Drugs Live Price Chart



Loading Fundamental data..


Loading data..
Is Concord Drugs Ltd. worth buying?
12 Votes:
Buy 66.67%
Sell 25.0%
Hold 8.33%
BUY
SELL
HOLD